Cytosorbents Corporation

Historical 13F Holders

Symbol
CTSO
CUSIP
23283X206
All holders as of
Q3 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 23283X206 since 12/18/2024, largest first.

Filer % of Class Filed
Avenir Corp 13G/A
8.3% 2/13/2026
Event 12/31/2025
Thomas A. Satterfield, Jr. 13G 6.6% 1/17/2025
Event 1/13/2025
Avenue Venture Opportunities Fund, L.P. 13G
5.7% 5/28/2025
Event 6/26/2024
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Skylands Capital, LLC 13G 4.8% 4/17/2025
Event 3/31/2025
Vanguard Group Inc 13G/A 3.1% 4/30/2025
Event 3/31/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 2 270 k $1.05M
2026 Q2 51 16.1 M $6.04M
2026 Q1 50 16.5 M $9.32M
2025 Q4 51 16.9 M $10.8M
2025 Q3 49 16.3 M $15.3M
2025 Q2 47 16.4 M $20.7M
2025 Q1 50 16.9 M $16.9M
2024 Q4 53 15.3 M $14.1M
2024 Q3 54 16.5 M $24.7M
2024 Q2 52 16.7 M $11.8M
2024 Q1 51 17.6 M $16.7M
2023 Q4 55 18.1 M $20.0M
2023 Q3 54 15.2 M $28.7M
2023 Q2 59 15.2 M $54.7M
2023 Q1 61 15.2 M $51.3M
2022 Q4 55 14.7 M $22.7M
2022 Q3 62 14.9 M $20.7M
2022 Q2 79 15.5 M $33.9M
2022 Q1 90 18.0 M $58.8M
2021 Q4 93 17.8 M $74.6M
2021 Q3 97 18.4 M $149M
2021 Q2 104 17.5 M $132M
2021 Q1 99 17.5 M $153M
2020 Q4 95 17.6 M $140M
2020 Q3 97 17.2 M $137M
2020 Q2 95 11.3 M $111M
2020 Q1 84 9.95 M $76.8M
2019 Q4 74 8.94 M $34.4M
2019 Q3 71 8.45 M $42.5M
2019 Q2 73 8.55 M $56.5M
2019 Q1 80 8.52 M $64.6M
2018 Q4 87 8.66 M $69.9M
2018 Q3 82 8.26 M $107M
2018 Q2 77 7.91 M $90.0M
2018 Q1 49 3.93 M $27.7M
2017 Q4 45 3.21 M $20.9M
2017 Q3 32 2.48 M $15.4M
2017 Q2 34 1.94 M $8.34M
2017 Q1 38 2.45 M $11.1M
2016 Q4 39 1.59 M $8.69M
2016 Q3 38 1.57 M $10.0M
2016 Q2 36 1.77 M $8.06M
2016 Q1 35 1.41 M $5.51M
2015 Q4 39 1.38 M $7.66M
2015 Q3 34 1.35 M $8.52M
2015 Q2 31 1.24 M $7.63M
2015 Q1 28 908 k $11.9M
2014 Q4 9 394 k $3.92M